Soter Technologies Introduces Rapid Walk-Through Health Detection Scanner
Soter Technologies’ team of engineers and medical advisors have been working around the clock since December 2019 to create, design and build technology to help reduce the spread of the COVID-19 pandemic, other illnesses and to aid with the re-opening of the economy.
Soter Technologies announced today that the SymptomSense™ Medical Evaluation Gateway, a non-invasive walk-through electronic full-body symptom scanner for providing detection of symptoms of known illness in less than 10 seconds is now moving into the production phase.
SymptomSense™ is a electronic walk-through full-body health scanner that looks similar to metal detectors used at security checkpoints of airports, sporting events and government buildings. Similar to the rapid evaluation that an individual would receive at a hospital emergency room SymptomSense™ gathers critical vitals including blood oxygen level, which is more important than body temperature, when assessing if an individual is ill.
SymptomSense™ uses an array of sensors to provide a rapid, non-invasive, hands-free approach for gaining important real-time vital signs, including detecting: blood oxygen levels, external body temperature within 0.2 degrees of accuracy, elevated heart rate, respiration rate, shortness of breath, lung congestion, height, weight and, in the future, non-contact blood pressure. Within seconds the SymptomSense™ device provides health status with clear messaging and indicators for screening staff, and, in the future, data mapping of alerts to an electronic system-of-records that can be shared with authorities as may be required per local laws and ordinances.
“To get the economy going, open schools and allow for people to safely work and gather we need to use sensor technology and continue to follow recommended safety protocols. At Soter we identified months ago, with our medical advisors, that it is critical to check body temperature. However, to get a better idea if an individual is ill, we also determined that we would need to know blood oxygen level, check heart and respiration rates and identify if there is lung congestion. Our technology combines all this data to make a more effective identification of potential illness,” Derek Peterson, CEO of Soter Technologies.
The development and beta testing of prototypes started in late 2019 in response to the COVID-19 outbreak in China. Fortune 100 companies, major league professional sports teams, entertainment parks, Broadway theater management companies, real estate development and management companies, U.S. federal government departments and governments around the globe have all expressed interest and are reviewing SymptomSense™ for potential use.
SymptomSense™ allows on-site security personnel to rapidly screen and use the Soter’s AI (Artificial Intelligence) technology to identify individuals with known symptoms prior to entry into hospitals, schools, airports, train stations, government buildings, military bases, stadiums, malls, and other such facilities that must remain open. Soter has accepted orders from clients in the United States, Europe and countries around the world with delivery of the first units set for June 2020. The company formed an Advisory Board of doctors, scientists and engineers that continues to work with the medical and research community to enhance the systems’ technology and capabilities. For example, SymptomSense™ now includes a module for weapons detection to provide property managers with an all-in-one access reassurance solution.
SymptomSense™ can scan approximately 1,500 people per hour and is capable of processing more than 10,000 people over an 8-hour period, with zero downtime. For airline and other transportation systems, an optional built-in facial recognition technology is available for data-mapping to government registry. In doing so, SymptomSense™ platform enables building / site security personnel to track the movement of potential carriers of a virus, while protecting their privacy. This data capture and mapping capability is critical for understanding the current and predictive patterns, and trending for the spread of disease, and then help trace back to most-current disease geo-location clustering and origin. As needed, the platform can be linked to mobile phone “contact tracing” data, local weather data, and demographic data as may be required by government agencies.
The company accepting United States and international orders for SymptomSense™ Scanners. This health and safety technology platform can be deployed rapidly and is easy to use.